Last updated on March 2019

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes


Brief description of study

The main purpose of this study is to evaluate the safety of a study drug known as LY3209590 in Japanese participants with type 2 diabetes. Side effects and tolerability will be documented. Blood samples will be taken to compare how the body handles the drug and how it affects blood sugar levels. The study will last about four weeks, not including screening. Screening is required within 4 weeks before the start of the study.

Clinical Study Identifier: NCT03603704

Contact Investigators or Research Sites near you

Start Over

Sumida Hospital

Sumida-ku, Japan
0.53miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.